IRWD Ironwood Pharmaceuticals Inc.

15.04
-0.36  -2%
Previous Close 15.40
Open 15.53
Price To book 501.33
Market Cap 2249862537
Shares 149,591,924
Volume 1,439,868
Short Ratio 16.43
Av. Daily Volume 1,119,670

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approval announced August 21, 2017.
DUZALLO (LESINURAD AND ALLOPURINOL)
Hyperuricemia associated with gout
Phase 2a data due 2H 2017.
IW-1973
Type 2 diabetes
Phase 2a data due 2H 2017.
IW-1973
Type 2 diabetes
sNDA approval announced January 26, 2017.
Linaclotide 72 mcg dose for use in the treatment of adults
Chronic idiopathic constipation (CIC)
Phase 2b data released December 22, 2016. Phase 3 trials to be initiated in 2H 2017.
Linaclotide Colonic Release
Irritable Bowel Syndrome with Constipation (IBS-C)
Phase 2a data released April 2016. Development to be discontinued due to disappointing data
IW-9179
Gastroparesis
Phase 2b data released July 20, 2017. Primary endpoint met but data below expectations.
IW-3718
Gastroesophageal reflux disease (GERD)

Latest News

  1. See what the IHS Markit Score report has to say about Ironwood Pharmaceuticals Inc.
  2. Ironwood Pharmaceuticals, Inc. – Value Analysis (NASDAQ:IRWD) : October 16, 2017
  3. ETFs with exposure to Ironwood Pharmaceuticals, Inc. : October 16, 2017
  4. Ironwood Pharmaceuticals Presenting Linaclotide Data at the World Congress of Gastroenterology at ACG 2017
  5. Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bearish Manner : IRWD-US : October 13, 2017
  6. Don’t Miss Out On These Tantalizing Sohn Conference Stock Pitches
  7. Ironwood Pharmaceuticals, Inc. breached its 50 day moving average in a Bullish Manner : IRWD-US : September 26, 2017
  8. ETFs with exposure to Ironwood Pharmaceuticals, Inc. : September 13, 2017
  9. Ironwood Pharmaceuticals, Inc. :IRWD-US: Earnings Analysis: Q2, 2017 By the Numbers : September 11, 2017
  10. Ironwood Pharmaceuticals Announces Leadership Change
  11. Why Is Ironwood (IRWD) Down 4.1% Since the Last Earnings Report?
  12. Ironwood Pharmaceuticals to Present at Upcoming September Investor Conferences
  13. Today's Research Reports on Stocks to Watch: Medtronic and Ironwood Pharmaceuticals
  14. Biotech Stock Roundup: EU Label Expansion for Alexion, BIIB Facing Drug Price Probe
  15. Ironwood Pharma's Combination Gout Drug Gets FDA Approval